The Boulder, CO, site is scheduled to become operational in the second half of 2027, following completion and qualification.

Venetoclax, a cancer drug that inhibits BCL-2, reduced the intact SIV reservoir in macaques and may inform future HIV cure ...

Preclinical findings are the basis for an upcoming Phase II clinical trial evaluating psilocybin during chemotherapy in ...

Cell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but ...

Results show that eliminating dendritic cells from the lymph nodes wiped out elevated levels of T cells in mice, and slowed cognitive decline.

New research models plasmid competition in E. coli, with implications for biotechnology, antibiotics, and probiotics.

Study identifies a gene that could potentially be targeted in human pancreatic duct cells to replenish β cell mass for ...

The DARPA project had the potential to improve athletic performance and help treat conditions involving a lack of oxygen in ...

Manufacturing activities are expected to include process optimization, scale-up, analytical qualification, and potency assay ...

A new spatial transcriptomics framework compares tumor “floor plans,” revealing conserved spatial groups that may relate ...

Moderna and Merck & Co. saw their stocks surge after announcing what they said were the first-ever positive Phase III results ...